Error: Could not add to watchlist. X

Allianz Global Investors Global Biotech Fund

+ Watchlist
DREGBIO:TT
33.21
TWD
0.20
0.60%
As of 07:52:00 ET on 02/04/2016.
Fund Type
Unit Trust
52Wk Range
32.87 - 45.42
1 Yr Return
-9.31%
YTD Return
-18.86%
Previous Close
33.41
52Wk Range
32.87 - 45.42
1 Yr Return
-9.21%
YTD Return
-18.86%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/04/2016)
33.21
Total Assets (b TWD) (on 12/31/2015)
6.225
Inception Date
06/28/2002
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
CHIH-WEI HSU
Front Load Fee
2.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.80%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Alexion Pharmaceuticals Inc 90.21 k 566.40 m 9.10
Amgen Inc 98.04 k 523.88 m 8.42
Regeneron Pharmaceuticals Inc 21.55 k 385.04 m 6.19
Celgene Corp 81.77 k 322.34 m 5.18
Mylan NV 177.00 k 315.02 m 5.06
Biogen Inc 29.33 k 295.79 m 4.75
Vertex Pharmaceuticals Inc 69.86 k 289.33 m 4.65
Gilead Sciences Inc 78.25 k 260.65 m 4.19
Incyte Corp 72.33 k 258.19 m 4.15
Novartis AG 65.43 k 189.05 m 3.04
Profile
Allianz Global Investors Global Biotech Fund is an open-end unit trust establish ed in Taiwan. The Fund's objective is to seek long-term capital gain and secure stable income. The Fund invests primarily in equity securities issued by companies in the biotechnology sector. It also invests in local equities and government bonds (including convertibles) and financial debentures.
ADDRESS
Allianz Global Investors Taiwan Ltd
6F 378 Fu Shin North Road
Taipei
Taiwan
PHONE
886-2-2502-8889